Patent US4244945A successfully refreshed from Google Patents.
US4244945A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Biologically active substance
Assignee: SmithKline Beecham Corp
•
Filing: 1979-04-16
•
Granted: 1981-01-13
•
Expires: 1999-04-16
Abstract
Abstract A method for the induction and/or maintenance of anaesthesia or of neuroleptanalgesia in a mammal comprising the administration to the mammal of an anaesthetic-effective or of a neuroleptanalgesic-effective, non-toxic amount of a peptide of formula H.Tyr.D-Ala.Gly.Phe.D-Leu.
Inventors
- 👤 Samuel Wilkinson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 21:50
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/665; C07K14/675; C07K14/6755; C07K14/70; C07K14/702
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
39 words
A method for the induction and/or maintenance of neuroleptanalgesia in a mammal, comprising the administration to the mammal of a neuroleptanalgesic-effective, non-toxic amount of a peptide of formula H.Tyr.D-Ala.Gly.Phe.D-Leu.NHEt or a pharmacologically and pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim
39 words
A method for the induction and/or maintenance of neuroleptanalgesia in a mammal, comprising the administration to the mammal of a neuroleptanalgesic-effective, non-toxic amount of a peptide of formula H.Tyr.D-Ala.Gly.Phe.D-Leu.NHEt or a pharmacologically and pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
32 words
A method according to claim 1 wherein a pharmaceutical formulation comprising the peptide or acid addition salt thereof together with a pharmaceutically and pharmacologically acceptable carrier therefor is administered to the mammal.
Claim 4
Dependent Claim
39 words
A method according to claim 1 wherein the peptide or acid addition salt thereof is administered at a dosage in the range of from 0.0025 μg to 40 mg per kilogramme bodyweight of the mammal, calculated as the base.
Claim 5
Dependent Claim
11 words
A method according to claim 1 wherein the mammal is man.
Claim 6
Dependent Claim
20 words
The method of claim 1 in which the peptide or salt thereof is administered with a pharmaceutically acceptable carrier therefore.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-01-13 | 1984-07-14 | 1985-01-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-01-13 | 1988-07-14 | 1989-01-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-01-13 | 1992-07-14 | 1993-01-13 | $7700.00 | Window Closed / Lapsed |